Literature DB >> 19633842

Positron emission tomography for the evaluation of soft-tissue sarcomas and bone sarcomas.

Cristina Nanni, Maria Cristina Marzola, Domenico Rubello, Stefano Fanti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19633842     DOI： 10.1007/s00259-009-1222-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  15 in total

1.  Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.

Authors:  M Weyl Ben Arush; O Israel; S Postovsky; D Militianu; I Meller; I Zaidman; A Even Sapir; R Bar-Shalom
Journal:  Pediatr Blood Cancer       Date:  2007-12       Impact factor: 3.167

2.  Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging.

Authors:  Ukihide Tateishi; Umio Yamaguchi; Testuo Maeda; Kunihiko Seki; Takashi Terauchi; Akira Kawai; Yasuaki Arai; Noriyuki Moriyama; Tadao Kakizoe
Journal:  Cancer Sci       Date:  2006-10       Impact factor: 6.716

3.  FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.

Authors:  Mathieu Charest; Marc Hickeson; Robert Lisbona; Javier-A Novales-Diaz; Vilma Derbekyan; Robert E Turcotte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

4.  Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome.

Authors:  Janet F Eary; Finbarr O'Sullivan; Janet O'Sullivan; Ernest U Conrad
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

5.  Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET.

Authors:  Zhaoming Ye; Jiangjun Zhu; Mei Tian; Hong Zhang; Hongwei Zhan; Chunlei Zhao; Disheng Yang; Weixu Li; Nong Lin
Journal:  Ann Nucl Med       Date:  2008-08-01       Impact factor: 2.668

6.  Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.

Authors:  Ukihide Tateishi; Umio Yamaguchi; Kunihiko Seki; Takashi Terauchi; Yasuaki Arai; E Edmund Kim
Journal:  Radiology       Date:  2007-12       Impact factor: 11.105

7.  Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine.

Authors:  Andreas K Buck; Ken Herrmann; Christian Meyer Zum Büschenfelde; Malik E Juweid; Mark Bischoff; Gerhard Glatting; Gregor Weirich; Peter Möller; Hans-Jürgen Wester; Klemens Scheidhauer; Tobias Dechow; Christian Peschel; Markus Schwaiger; Sven N Reske
Journal:  Clin Cancer Res       Date:  2008-04-29       Impact factor: 12.531

Review 8.  Sarcoma.

Authors:  Keith M Skubitz; David R D'Adamo
Journal:  Mayo Clin Proc       Date:  2007-11       Impact factor: 7.616

9.  Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression.

Authors:  Junko Sato; Takashi Yanagawa; Yoh Dobashi; Takehiko Yamaji; Kenji Takagishi; Hideomi Watanabe
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

10.  Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.

Authors:  Thomas Völker; Timm Denecke; Ingo Steffen; Daniel Misch; Stefan Schönberger; Michail Plotkin; Juri Ruf; Christian Furth; Brigitte Stöver; Hubertus Hautzel; Günter Henze; Holger Amthauer
Journal:  J Clin Oncol       Date:  2007-12-01       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.